I find it plausible that it's often a good idea in medicine to be conservative before launching interventions that may have adverse side effects, but have difficulty swallowing the idea that this conservatism should be implemented by reducing visibility (eg by not applying tests too broadly if they have a nontrivial false positive rate and the condition is rare). It seems like the right thing to do would be to maximize visibility, but then to try to corroborate and not overreact to apparent positives.